Offaly Live · Aug 20, 2026
People suffering from rare disease ‘beg’ for life-changing medicine
0Sign in to vote or save

The HSE Drugs Group decided to recommend that the drug Skyclarys, used for Friedreich’s ataxia (FA), should not be covered by the HSE.

Comments
Nothing yet. Say the first thing.
Sign in to join the conversation.